Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Accuray Incorporated

ARAY
Current price
2.64 USD +0.14 USD (+5.60%)
Last closed 2.54 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 246 563 392 USD
Yield for 12 month +30.69 %
Week
Month
Year
ARAY
21.11.2021 - 28.11.2021

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. Address: 1310 Chesapeake Terrace, Sunnyvale, CA, United States, 94089

Analytics

WallStreet Target Price

8.5 USD

P/E ratio

Dividend Yield

10.1 %

Current Year

+447 605 000 USD

Last Year

+429 909 000 USD

Current Quarter

+103 892 000 USD

Last Quarter

+118 292 000 USD

Current Year

+153 960 000 USD

Last Year

+159 955 000 USD

Current Quarter

+39 493 000 USD

Last Quarter

+37 678 000 USD

Key Figures ARAY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 11 379 000 USD
Operating Margin TTM 3.73 %
PE Ratio
Return On Assets TTM 0.9 %
PEG Ratio 0.08
Return On Equity TTM -13.89 %
Wall Street Target Price 8.5 USD
Revenue TTM 455 004 000 USD
Book Value 0.53 USD
Revenue Per Share TTM 4.76 USD
Dividend Share
Quarterly Revenue Growth YOY 16.8 %
Dividend Yield 10.1 %
Gross Profit TTM 153 960 000 USD
Earnings Share -0.07 USD
Diluted Eps TTM -0.07 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -96.2 %
Profit Margin -1.49 %

Dividend Analytics ARAY

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ARAY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 10.1 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ARAY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.8232
Price Sales TTM 0.5419
Enterprise Value EBITDA 28.4245
Price Book MRQ 4.8399

Financials ARAY

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ARAY

For 52 weeks

1.85 USD 4.3 USD
50 Day MA 2.72 USD
Shares Short Prior Month 5 878 697
200 Day MA 3.16 USD
Short Ratio 15.42
Shares Short 5 577 966
Short Percent 5.84 %